SRSF1 and Miyoshi myopathy: Notably, SRSF1 overexpression was associated with worse clinical characteristics in MM patients (age, ISS stage, amplification of 1q21, relapse statuses as well as beta-2 microglobulin) and predicts poor OS and EFS of MM patients.